RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN)

RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN), a publicly-traded biopharmaceutical company, focuses their efforts on discovering and developing innovative molecules that increase the speed of tissue and organ repair. With headquarters in Bethesda, Maryland, the company leverages its outsourcing business model to efficiently control costs while developing drug candidates. RegeneRX believes this business model improves their ability to rapidly allocate resources to various projects without investing in infrastructure. For further information, visit the Company’s web site at www.regenerx.com.